DRUG · Unmapped registry intervention
Picoplatin
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
NCT00448734
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hormone Refractory Prostate Cancerunresolved
Interventions
PicoplatinDRUG
docetaxelDRUG · verified · RxNorm: docetaxel
Sponsors & collaborators
Poniard Pharmaceuticalslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00448734 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.